NCT05137236 - A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters | Biotech Hunter

Enrollment

540

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL

mRNA-1283

Sterile liquid for injection

BIOLOGICAL

mRNA-1283.211

Sterile liquid for injection

BIOLOGICAL

mRNA-1273

Sterile liquid for injection

BIOLOGICAL

mRNA-1283.529

Sterile liquid for injection

Trial Locations (17)

14609

Rochester Clinical Research, Inc., Rochester

30341

Tekton Research, Chamblee

45212

CTI Clinical Research Center, Cincinnati

68510

Meridian Clinical Research (Nebraska), Lincoln

70006

MedPharmics, Metairie

77008

Ventavia Research Group, Houston

85015-1105

MedPharmics, LLC, Phoenix

33024-2709

Research Centers of America, Hollywood

33351-7311

Precision Clinical Research, Sunrise

01655-0002

UMass Memorial Medical Center, Worcester

55402-2700

Clinical Research Institute, Inc - CRN, Minneapolis

87102-3876

MedPharmics, LLC. - Albuquerque, Albuquerque

45246-2316

Meridian Clinical Research (Cincinnati), Cincinnati

43213-6517

Aventiv Research Inc, Columbus

29405-4986

Coastal Carolina Research Center, North Charleston

75033-4135

ACRC Trials, Frisco

23606-4537

Health Research of Hampton Roads Inc., Newport News

All Listed Sponsors

lead

ModernaTX, Inc.

INDUSTRY